Form 4: EyePoint Pharmaceuticals Director Buys Shares
Insider Transaction (Form 4)
Karen L. Zaderej, a Director of EyePoint Pharmaceuticals, Inc., purchased 10,600 shares of common stock on August 18, 2026 for $4.93 per share.
Summary
- Open-market purchase: acquired 10,600 Common Stock at $4.93 ($52,258) on August 18, 2026; holds 49,100 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $52,258, committing personal capital to the stock.
Insider Transactions
Karen L. Zaderej — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-18 | Open-market purchase | Common Stock | 10,600 | $5 | $52.3K | 49,100 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-18 | Open-market purchase (10,600 shares) |
Keywords
insider transaction, Form 4, EYPT, EyePoint, Inc., bullish, Karen L. Zaderej
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.